PRE 14A

PRELIMINARY PROXY STATEMENT

Company: ORAMED PHARMACEUTICALS INC.
Filed: July 20, 2017
Period of Report: July 20, 2017
Accession Number: 0001213900-17-007770

View Document ↗ View on SEC.gov ↗